William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Cotiviti Holdings, Inc. (COTV) to Offer 10M Shares for Holders
-
Kinsale Capital Group (KNSL) to Offer 2.8M Common Shares
-
Kinsale Capital Group, Inc. Announces Secondary Offering of Common Stock
-
SiteOne Landscape Supply (SITE) Commences 8M Share Common Stock Secondary Offering
-
SiteOne Landscape Supply, Inc. Announces Launch of Secondary Public Offering of Common Stock
-
Bojangles' (BOJA) Announces 6M Share Common Stock Secondary Offering
-
Bojangles’, Inc. Announces Proposed Secondary Offering of Common Stock
-
Cotiviti Announces Secondary Public Offering
-
Elliott Management Sends Letter to Cognizant (CTSH) Outlining Three-Part 'Value-Enhancement Plan'
-
Elliott Management Sends Letter to Cognizant Technology Solutions Corporation Outlining Value-Enhancement Plan
-
Airgain (AIRG) Files for $40M Common Stock Offering; Holders to Sell $20M
-
Airgain Files S-1 Registration Statement for Proposed Primary and Secondary Offering
-
BeiGene Announces Closing of $200 Million Public Offering
-
Bed Bath & Beyond (BBBY) Acquires PMall.com for $190M
-
Bed Bath & Beyond Inc. Acquires PersonalizationMall.com
-
William Blair Downgrades Cognizant Technology Solutions (CTSH) to Market Perform
-
Fox Factory Holding Corp. Announces Closing of Secondary Public Offering
-
William Blair Starts BlackLine (BL) at Outperform
-
University of Texas Wins Investment Manangemt Challenge at UNC Kenan-Flagler Business School
-
Spring Bank Pharmaceuticals Announces Financing of $15 Million
-
BeiGene (BGNE) Prices 6.25M ADS Follow-on Offering for Proceeds of $200M
-
Aclaris Therapeutics (ACRS) Prices 4M Stock Offering at $22.75/Share
-
BeiGene Announces Pricing of $200 Million Public Offering
-
Aclaris Announces Pricing of Public Offering of Common Stock
-
nThrive™ Signs Agreement to Acquire Independent Revenue Cycle Services Organization
-
William Blair Downgrades Markel Corp (MKL) to Market Perform
-
William Blair Downgrades Navigators Group (NAVG) to Market Perform
-
William Blair Downgrades Travelers (TRV) to Underperform
-
William Blair Downgrades Chubb Corporation (CB) to Underperform
-
Fox Factory Holding (FOXF) Announces 3.5M Share Common Stock Secondary Offering
-
Fox Factory Holding Corp. Announces Secondary Public Offering
-
Aclaris Therapeutics (ACRS) to Offer up to $65M in Stock
-
Aclaris Announces Proposed Public Offering of Common Stock
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Sep 30
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Sep 30
-
Is there profit in Mexico's Trump slump? Funds divided
-
Paylocity Announces Ellen Carnahan Joining Board of Directors
-
William Blair Bullish on Filtration, Water Management Following Trump Victory (LNN) (VMI)
-
William Blair Downgrades Globus Medical (GMED) to Market Perform
-
Streetinsider.com's Hot Lunchtime Reads 11/7: (WATT) (ACIA) (LC) (IONS)
-
Acacia Communications (ACIA) Gains on 'Big Win' at Facebook, Notes William Blair
-
William Blair Downgrades Fluor (FLR) to Market Perform
-
William Blair Downgrades El Pollo Loco (LOCO) to Market Perform
-
BlackLine Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
-
William Blair Downgrades Tableau Software (DATA) to Market Perform
-
William Blair Downgrades Vertex (VRTX) to Market Perform
-
Biohaven Secures $80 Million in Oversubscribed Private Financing to Advance Phase 3 Clinical Trials
-
Biohaven Secures $80 Million in Oversubscribed Private Financing to Advance Phase 3 Clinical Trials
-
Notable Analyst Rating Changes 10/31: (VMW) (M) (TEVA) Upgraded; (NKE) (ABBV) (JWN) Downgraded
-
William Blair Starts Acacia Communications (ACIA) at Outperform

